879 related articles for article (PubMed ID: 16792748)
21. Inhibition of scratching behavior associated with allergic dermatitis in mice by tacrolimus, but not by dexamethasone.
Inagaki N; Shiraishi N; Igeta K; Itoh T; Chikumoto T; Nagao M; Kim JF; Nagai H
Eur J Pharmacol; 2006 Sep; 546(1-3):189-96. PubMed ID: 16914137
[TBL] [Abstract][Full Text] [Related]
22. Enhanced production and secretion of glial cell line-derived neurotrophic factor and nerve growth factor from the skin in atopic dermatitis mouse model.
Tokime K; Katoh-Semba R; Yamanaka K; Mizoguchi A; Mizutani H
Arch Dermatol Res; 2008 Aug; 300(7):343-52. PubMed ID: 18443810
[TBL] [Abstract][Full Text] [Related]
23. Effect of suplatast tosilate on goblet cell metaplasia in patients with asthma.
Hoshino M; Fujita Y; Saji J; Inoue T; Nakagawa T; Miyazawa T
Allergy; 2005 Nov; 60(11):1394-400. PubMed ID: 16197471
[TBL] [Abstract][Full Text] [Related]
24. Effects of topically applied Korean red ginseng and its genuine constituents on atopic dermatitis-like skin lesions in NC/Nga mice.
Kim HS; Kim DH; Kim BK; Yoon SK; Kim MH; Lee JY; Kim HO; Park YM
Int Immunopharmacol; 2011 Feb; 11(2):280-5. PubMed ID: 21118672
[TBL] [Abstract][Full Text] [Related]
25. Suppressive effects of anti-allergic agent suplatast tosilate (IPD-1151T) on the expression of co-stimulatory molecules on mouse splenocytes in vivo.
Kurokawa M; Kawazu K; Asano K; Fumio K; Mita A; Adachi M
Mediators Inflamm; 2001 Dec; 10(6):333-7. PubMed ID: 11817674
[TBL] [Abstract][Full Text] [Related]
26. Administration of Ag85B showed therapeutic effects to Th2-type cytokine-mediated acute phase atopic dermatitis by inducing regulatory T cells.
Mori H; Yamanaka K; Matsuo K; Kurokawa I; Yasutomi Y; Mizutani H
Arch Dermatol Res; 2009 Feb; 301(2):151-7. PubMed ID: 18633632
[TBL] [Abstract][Full Text] [Related]
27. Intravesical suplatast tosilate (IPD-1151T) inhibits experimental bladder inflammation.
Boucher W; Kempuraj D; Cao J; Papaliodis D; Theoharides TC
J Urol; 2007 Mar; 177(3):1186-90. PubMed ID: 17296442
[TBL] [Abstract][Full Text] [Related]
28. CCL27 is a critical factor for the development of atopic dermatitis in the keratin-14 IL-4 transgenic mouse model.
Chen L; Lin SX; Agha-Majzoub R; Overbergh L; Mathieu C; Chan LS
Int Immunol; 2006 Aug; 18(8):1233-42. PubMed ID: 16735375
[TBL] [Abstract][Full Text] [Related]
29. Tolerogenic antigen-presenting cells successfully inhibit atopic dermatitis-like skin lesion induced by repeated epicutaneous exposure to ovalbumin.
Katagiri K; Arakawa S; Hatano Y; Fujiwara S
Arch Dermatol Res; 2008 Nov; 300(10):583-93. PubMed ID: 18528699
[TBL] [Abstract][Full Text] [Related]
30. [Cytokine production by peripheral blood mononuclear cells in bronchial asthma treated with suplatast tosilate].
Yamasawa H; Oshikawa K; Sugiyama Y
Arerugi; 2001 Jun; 50(6):513-9. PubMed ID: 11517513
[TBL] [Abstract][Full Text] [Related]
31. Effects of Catalpa ovata stem bark on atopic dermatitis-like skin lesions in NC/Nga mice.
Yang G; Choi CH; Lee K; Lee M; Ham I; Choi HY
J Ethnopharmacol; 2013 Jan; 145(2):416-23. PubMed ID: 23195129
[TBL] [Abstract][Full Text] [Related]
32. COX-2 inhibition enhances the TH2 immune response to epicutaneous sensitization.
Laouini D; Elkhal A; Yalcindag A; Kawamoto S; Oettgen H; Geha RS
J Allergy Clin Immunol; 2005 Aug; 116(2):390-6. PubMed ID: 16083795
[TBL] [Abstract][Full Text] [Related]
33. Topical delivery of interleukin-13 antisense oligonucleotides with cationic elastic liposome for the treatment of atopic dermatitis.
Kim ST; Lee KM; Park HJ; Jin SE; Ahn WS; Kim CK
J Gene Med; 2009 Jan; 11(1):26-37. PubMed ID: 19006098
[TBL] [Abstract][Full Text] [Related]
34. Topical application of Taglisodog-eum inhibits the development of experimental atopic dermatitis.
Hwang JS; Kim JE; Kim HT; Yu YB; Im SH
J Ethnopharmacol; 2013 Jan; 145(2):536-46. PubMed ID: 23211659
[TBL] [Abstract][Full Text] [Related]
35. DA-9601 suppresses 2, 4-dinitrochlorobenzene and dust mite extract-induced atopic dermatitis-like skin lesions.
Choi EJ; Lee S; Hwang JS; Im SH; Jun CD; Lee HS; Kim SH
Int Immunopharmacol; 2011 Sep; 11(9):1260-4. PubMed ID: 21511060
[TBL] [Abstract][Full Text] [Related]
36. Oral administration of Uncariae rhynchophylla inhibits the development of DNFB-induced atopic dermatitis-like skin lesions via IFN-gamma down-regulation in NC/Nga mice.
Kim DY; Jung JA; Kim TH; Seo SW; Jung SK; Park CS
J Ethnopharmacol; 2009 Apr; 122(3):567-72. PubMed ID: 19429328
[TBL] [Abstract][Full Text] [Related]
37. Topical application of Pleurotus eryngii extracts inhibits 2,4-dinitrochlorobenzene-induced atopic dermatitis in NC/Nga mice by the regulation of Th1/Th2 balance.
Choi JH; Kim HG; Jin SW; Han EH; Khanal T; Do MT; Hwang YP; Choi JM; Chun SS; Chung YC; Jeong TC; Jeong HG
Food Chem Toxicol; 2013 Mar; 53():38-45. PubMed ID: 23200891
[TBL] [Abstract][Full Text] [Related]
38. The inhibitory effect of anti-allergic agent suplatast tosilate (IPD-1151T) on methacholine- and allergen-induced bronchoconstriction in sensitized mice. asakazu@med.showa-u.dc.jp.
Asano K; Mizutani T; Shimane T; Hisano M; Hisamitsu T; Suzaki H
Mediators Inflamm; 2000; 9(2):77-84. PubMed ID: 10958380
[TBL] [Abstract][Full Text] [Related]
39. Topical application of aloperine improves 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice.
Yuan XY; Ma HM; Li RZ; Wang RY; Liu W; Guo JY
Eur J Pharmacol; 2011 May; 658(2-3):263-9. PubMed ID: 21371468
[TBL] [Abstract][Full Text] [Related]
40. Epicutaneous sensitization with superantigen induces allergic skin inflammation.
Laouini D; Kawamoto S; Yalcindag A; Bryce P; Mizoguchi E; Oettgen H; Geha RS
J Allergy Clin Immunol; 2003 Nov; 112(5):981-7. PubMed ID: 14610492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
